Immunotherapy for glioblastoma well tolerated; survival gains observed – EurekAlert (press release)
EurekAlert (press release) |
Immunotherapy for glioblastoma well tolerated; survival gains observed
EurekAlert (press release) DURHAM, N.C. — A phase one study of 11 patients with glioblastoma who received injections of an investigational vaccine therapy and an approved chemotherapy showed the combination to be well tolerated while also resulting in unexpectedly significant … |
